The approvals of Onpattro, Givlaari, Oxlumo, and Leqvio combined with several partnerships have bolstered Alnylam's cash balance, and the company concluded fiscal 2024 with $2.69 billion in cash, cash ...

1-4 About RNAi RNAi (RNA interference) is a natural cellular process ... or so,” and was recognized with the award of the 2006 Nobel Prize for Physiology or Medicine.6 By harnessing the natural ...

Co-founded by Craig Mello, who won the Nobel Prize for Physiology or Medicine in 2006 for his work on RNAi, the company says the technology could be used to treat central nervous system diseases ...

Starting in 2025, the Eylea franchise as a whole began to decline due to competitive pressure from long-acting Vabysmo, which competes with Eylea HD, and Pabvlu, a biosimilar version of the original ...

In fact, it has been instrumental in important discoveries that have been recognized with the Nobel Prize, such as programmed cell death, RNA interference and applications of the GFP protein.

The discovery of RNA interference made the theoretical fabrication of ethnic and racial weapons feasible. This technology, which was discovered in 1998 by American scientists Andrew Fire and Craig ...

“Newer RNA interference therapeutics, patisiran and vutrisiran, show significant promise as an effective treatment for transthyretin amyloid cardiomyopathy (ATTR-CM),” Farhan Naeem ...

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

An atomic clock research team from the National Time Service Center of the Chinese Academy of Sciences has proposed and ...

With over 750 million long RNA reads across 14 human cell lines, the Singapore Nanopore Expression (SG-NEx) dataset is designed to help researchers decode RNA complexity with greater precision ...